{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:34:58Z","timestamp":1784525698343,"version":"3.55.0"},"reference-count":222,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Chronic anemia is commonly diagnosed in older adults and serves an important indicator of both reactive and clonal conditions. Many underlying diseases, such as myelodysplastic syndromes and multiple myeloma, are more prevalent amongst the elderly, while novel therapeutic approaches have transformed pediatric disorders of poor prognosis, such as beta-thalassemia, to a chronic disease of older adults. Thus, the increasing prevalence of chronic anemia in older ages is largely attributed to more frequent diagnostic and therapeutic evaluations and demographic changes. The etiology of anemia in adults is complex, ranging from genetic mutations to bone marrow failure syndromes, chronic kidney disease, nutritional deficiencies, and inflammatory processes, while in some cases no clear etiology is found. For this reason, extensive research is ongoing to introduce novel therapeutic targets and improve quality of life. Management of anemia in adults depends on severity and especially on the underlying conditions of each patient. Metabolic pathway analyses have revealed alterations in various pathways, including glycolysis, pyruvate, propanoate, glycerophospholipid, galactose, fatty acid, starch, and sucrose metabolism along with fatty acid elongation in mitochondria, glycerolipid, glyoxylate, and dicarboxylate metabolism in adult patients with chronic anemia compared to healthy individuals, which may serve as potential new therapeutic targets. In this review, we aim to (i) summarize current evidence regarding metabolic disturbances in diseases of age-related hematopoietic dysregulation, being represented by multiple myeloma and myelodysplastic syndromes, and in \u03b2-thalassemia, a disease model of accelerating cellular aging; and (ii) describe novel therapeutic metabolic-targeted options for the aforementioned diseases, focusing on the need for continuous research in this field.<\/jats:p>","DOI":"10.3390\/cells14221788","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:37:52Z","timestamp":1763131072000},"page":"1788","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomic Investigation of Myelodysplastic Syndromes, Multiple Myeloma, and Homozygous \u03b2-Thalassemia"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7595-9939","authenticated-orcid":false,"given":"Elena","family":"Chatzikalil","sequence":"first","affiliation":[{"name":"First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece"},{"name":"Aghia Sofia Children\u2019s Hospital ERN-PeadCan Center, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7833-4673","authenticated-orcid":false,"given":"Konstantinos","family":"Bistas","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece"},{"name":"Aghia Sofia Children\u2019s Hospital ERN-PeadCan Center, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0122-0318","authenticated-orcid":false,"given":"Vasiliki","family":"Kymioni","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-5944","authenticated-orcid":false,"given":"Panagiotis T.","family":"Diamantopoulos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Solomou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Patras Medical School, 26500 Rion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gaskell, H., Derry, S., Andrew Moore, R., and McQuay, H.J. (2008). Prevalence of Anaemia in Older Persons: Systematic Review. BMC Geriatr., 8.","DOI":"10.1186\/1471-2318-8-1"},{"key":"ref_2","first-page":"5","article-title":"Nutritional Anaemias. Report of a WHO Scientific Group","volume":"405","author":"Blanc","year":"1968","journal-title":"WHO Tech. Rep. Ser."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12185-012-1007-z","article-title":"Anemia and Mortality in Older Persons: Does the Type of Anemia Affect Survival?","volume":"95","author":"Shavelle","year":"2012","journal-title":"Int. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2017-07-746446","article-title":"Anemia at Older Age: Etiologies, Clinical Implications, and Management","volume":"131","author":"Stauder","year":"2018","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/gerona\/glv158","article-title":"Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study","volume":"71","author":"Schneider","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_6","first-page":"587","article-title":"The Prevalence and Impact of Anemia on Hospitalized Older Adults: A Single Center Experience from Bahrain","volume":"17","author":"Ahmed","year":"2022","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"ref_8","first-page":"563251","article-title":"Management of Anemia of Inflammation in the Elderly","volume":"2012","author":"Madeddu","year":"2012","journal-title":"Anemia"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bruserud, \u00d8., Vo, A.K., and Rekvam, H. (2022). Hematopoiesis, Inflammation and Aging\u2014The Biological Background and Clinical Impact of Anemia and Increased C-Reactive Protein Levels on Elderly Individuals. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030706"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Creang\u0103, E.-C., Stan, R., Nicolae, A.-C., Dr\u0103goi, C.M., and Dumitrescu, I.-B. (2025). Personalized Therapeutic Advances in Erythropoietin Signaling: From Anemia Management to Extensive Clinical Applications. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17091190"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kondoh, H., Kameda, M., and Yanagida, M. (2021). Whole Blood Metabolomics in Aging Research. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010175"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e00209","DOI":"10.1016\/j.mec.2022.e00209","article-title":"Metabolomics and Modelling Approaches for Systems Metabolic Engineering","volume":"15","author":"Khanijou","year":"2022","journal-title":"Metab. Eng. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small Molecule Metabolites: Discovery of Biomarkers and Therapeutic Targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hamany Djande, C.Y., Pretorius, C., Tugizimana, F., Piater, L.A., and Dubery, I.A. (2020). Metabolomics: A Tool for Cultivar Phenotyping and Investigation of Grain Crops. Agronomy, 10.","DOI":"10.3390\/agronomy10060831"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bmjnph-2024-000883","article-title":"Metabolomics-Based Treatment for Chronic Diseases: Results from a Multidisciplinary Clinical Study","volume":"7","author":"Tsoukalas","year":"2024","journal-title":"BMJ Nutr. Prev. Health"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Chatzikalil, E., Kalopitas, G., Patoulias, D., Popovic, D.S., Metallidis, S., Kotsa, K., Germanidis, G., and Koufakis, T. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144243"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chatzikalil, E., Asvestas, D., Tzeis, S., and Solomou, E.E. (2025). Clonal Hematopoiesis of Intermediate Potential in Atrial Fibrillation: A Critical View of Current Knowledge as a Springboard for Future Research. Diagnostics, 15.","DOI":"10.3390\/diagnostics15151915"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chatzikalil, E., Arvanitakis, K., Filippatos, F., Diamantopoulos, P.T., Koufakis, T., and Solomou, E.E. (2025). Diagnostic and Therapeutic Implications of the SUMOylation Pathway in Acute Myeloid Leukemia. Cancers, 17.","DOI":"10.3390\/cancers17040631"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12185-023-03666-z","article-title":"New-Onset Aplastic Anemia after SARS-CoV-2 Vaccination","volume":"118","author":"Chatzikalil","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chatzikalil, E., Roka, K., Diamantopoulos, P.T., Rigatou, E., Avgerinou, G., Kattamis, A., and Solomou, E.E. (2024). Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13072046"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kaiser, L., Weinschrott, H., Quint, I., Blaess, M., Csuk, R., Jung, M., Kohl, M., and Deigner, H.-P. (2020). Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways. Int. J. Mol. Sci., 21.","DOI":"10.1101\/2020.07.09.195156"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ebiom.2017.06.015","article-title":"Aging and Caloric Restriction Research: A Biological Perspective With Translational Potential","volume":"21","author":"Balasubramanian","year":"2017","journal-title":"eBioMedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.091777","article-title":"Stem Cell Metabolism in Tissue Development and Aging","volume":"140","author":"Daley","year":"2013","journal-title":"Development"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2020.02.008","article-title":"Caloric Restriction Reprograms the Single-Cell Transcriptional Landscape of Rattus Norvegicus Aging","volume":"180","author":"Ma","year":"2020","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1038\/s41467-018-06353-4","article-title":"Cell-Specific Proteome Analyses of Human Bone Marrow Reveal Molecular Features of Age-Dependent Functional Decline","volume":"9","author":"Hennrich","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/jacs.6b12822","article-title":"V Categorizing Cells on the Basis of Their Chemical Profiles: Progress in Single-Cell Mass Spectrometry","volume":"139","author":"Comi","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.tig.2023.08.005","article-title":"The Evolution of Aging and Lifespan","volume":"39","author":"Li","year":"2023","journal-title":"Trends Genet."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lokhov, P.G., Balashova, E.E., Maslov, D.L., Trifonova, O.P., and Archakov, A.I. (2024). Aging and Pathological Conditions Similarity Revealed by Meta-Analysis of Metabolomics Studies Suggests the Existence of the Health and Age-Related Metapathway. Metabolites, 14.","DOI":"10.3390\/metabo14110593"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Fang, W., Chen, S., Jin, X., Liu, S., Cao, X., and Liu, B. (2023). Metabolomics in Aging Research: Aging Markers from Organs. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1198794"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000452104","article-title":"Anaemia of Chronic Disease: An In-Depth Review","volume":"26","author":"Madu","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic Syndromes: 2023 Update on Diagnosis, Risk-Stratification, and Management","volume":"98","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sanchez-Villalobos, M., Blanquer Blanquer, M., Moraleda, J., Salido, E., and Perez-Oliva, A. (2022). New Insights Into Pathophysiology of \u03b2-Thalassemia. Front. Med., 9.","DOI":"10.3389\/fmed.2022.880752"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/thalassrep14040010","article-title":"Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment","volume":"14","author":"Sadiq","year":"2024","journal-title":"Thalass. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes: A Review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100940","DOI":"10.1016\/j.xcrm.2023.100940","article-title":"Emerging Treatments for Myelodysplastic Syndromes: Biological Rationales and Clinical Translation","volume":"4","author":"Adema","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of Glucose, Fatty Acid and Amino Acid Metabolism for Cancer Progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2017.1.73","article-title":"Aging, Hematopoiesis, and the Myelodysplastic Syndromes","volume":"2017","author":"Chung","year":"2017","journal-title":"Hematology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1182\/bloodadvances.2020002127","article-title":"Cell Interactions in the Bone Marrow Microenvironment Affecting Myeloid Malignancies","volume":"4","author":"Kokkaliaris","year":"2020","journal-title":"Blood Adv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.devcel.2020.06.029","article-title":"Hematopoietic Stem Cell Metabolism during Development and Aging","volume":"54","author":"Ito","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.stem.2011.09.010","article-title":"Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche","volume":"9","author":"Suda","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1\u03b1 Level Is Essential for Hematopoietic Stem Cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2018-10-844639","article-title":"The Mesenchymal Niche in MDS","volume":"133","author":"Pronk","year":"2019","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","article-title":"Mesenchymal Stem Cells and Their Microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00018-017-2725-4","article-title":"Role of the Microenvironment in Myeloid Malignancies","volume":"75","author":"Goulard","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00018-019-03017-4","article-title":"Determinants of Stem Cell Lineage Differentiation toward Chondrogenesis versus Adipogenesis","volume":"76","author":"Zhou","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbrc.2007.05.054","article-title":"Hypoxia Enhances Proliferation and Tissue Formation of Human Mesenchymal Stem Cell","volume":"358","author":"Grayson","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does It Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/jcp.22605","article-title":"The Metabolism of Human Mesenchymal Stem Cells During Proliferation and Differentiation","volume":"226","author":"Pattappa","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1182\/blood-2021-150749","article-title":"Unique Metabolic Vulnerabilities of Myelodysplastic Syndrome Stem Cells","volume":"138","author":"Stevens","year":"2021","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","article-title":"Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors","volume":"28","author":"Jones","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Patel, S.B., Nemkov, T., D\u2019Alessandro, A., and Welner, R.S. (2022). Deciphering Metabolic Adaptability of Leukemic Stem Cells. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.846149"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/ijms16022366","article-title":"Oxidative Stress, Bone Marrow Failure, and Genome Instability in Hematopoietic Stem Cells","volume":"16","author":"Richardson","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Poulaki, A., Katsila, T., Stergiou, I.E., Giannouli, S., G\u03ccmez-Tamayo, J.C., Piperaki, E.-T., Kambas, K., Dimitrakopoulou, A., Patrinos, G.P., and Tzioufas, A.G. (2020). Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts. Cancers, 12.","DOI":"10.3390\/cancers12123520"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Gong, T., Zheng, C., Ou, X., Zheng, J., Yu, J., Chen, S., Duan, Y., and Liu, W. (2022). Glutamine Metabolism in Cancers: Targeting the Oxidative Homeostasis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.994672"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine Reliance in Cell Metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"79722","DOI":"10.18632\/oncotarget.12944","article-title":"Inhibiting Glutaminase in Acute Myeloid Leukemia: Metabolic Dependency of Selected AML Subtypes","volume":"7","author":"Matre","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","article-title":"Tryptophan Metabolism as a Pharmacological Target","volume":"42","author":"Modoux","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2567.2002.01526.x","article-title":"Tryptophan Deprivation Sensitizes Activated T Cells to Apoptosis Prior to Cell Division","volume":"107","author":"Lee","year":"2003","journal-title":"Immunology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/01635581.2021.1960389","article-title":"Effects of Fatty Acids on Hematological Neoplasms: A Mini Review","volume":"74","author":"Giannattasio","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer Metabolism: Fatty Acid Oxidation in the Limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH Mutations in Cancer and Progress toward Development of Targeted Therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13908","DOI":"10.1074\/jbc.274.20.13908","article-title":"Mechanisms of Protection of Catalase by NADPH","volume":"274","author":"Kirkman","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_63","first-page":"1436","article-title":"Targeting 2-Oxoglutarate Dehydrogenase for Cancer Treatment","volume":"12","author":"Chang","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajh.23596","article-title":"IDH Mutations Are Closely Associated with Mutations of DNMT3A, ASXL1 and SRSF2 in Patients with Myelodysplastic Syndromes and Are Stable during Disease Evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The Implications of IDH Mutations for Cancer Development and Therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3324\/haematol.2022.281607","article-title":"IDH Mutations Are Enriched in Myelodysplastic Syndrome Patients with Severe Neutropenia and Can Be a Potential for Targeted Therapy","volume":"108","author":"Komrokji","year":"2022","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/c1mt00082a","article-title":"Disorders Associated with Systemic or Local Iron Overload: From Pathophysiology to Clinical Practice","volume":"3","author":"Sebastiani","year":"2011","journal-title":"Metallomics"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chatzikalil, E., Arvanitakis, K., Kalopitas, G., Florentin, M., Germanidis, G., Koufakis, T., and Solomou, E.E. (2025). Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches. Cancers, 17.","DOI":"10.3390\/cancers17030392"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"S\u0142omka, A., Pokrzywa, A., Strza\u0142a, D., Kubiaczyk, M., Weso\u0142owska, O., Denkiewicz, K., and Styczynski, J. (2024). The Role of Hepcidin in Myelodysplastic Syndromes (MDS): A Systematic Review of Observational Studies. Cancers, 16.","DOI":"10.3390\/cancers16020332"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body Iron Metabolism and Pathophysiology of Iron Overload","volume":"88","author":"Kohgo","year":"2008","journal-title":"Int. J. Hematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/713609210","article-title":"Iron Metabolism in the Reticuloendothelial System","volume":"38","author":"Knutson","year":"2003","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Frascatani, R., Colella, M., and Monteleone, G. (2024). Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer. Cancers, 16.","DOI":"10.3390\/cancers16234068"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ajh.26090","article-title":"Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS) and MDS\/Myeloproliferative Neoplasm with RS and Thrombocytosis (MDS\/MPN-RS-T)\u2014\u201c2021 Update on Diagnosis, Risk-Stratification, and Management\u201d","volume":"96","author":"Patnaik","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_75","first-page":"305","article-title":"IL-6-STAT-3-Hepcidin: Linking Inflammation to the Iron Metabolism","volume":"45","author":"Stoian","year":"2007","journal-title":"Rom. J. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood.2021014054","article-title":"Erythroid Overproduction of Erythroferrone Causes Iron Overload and Developmental Abnormalities in Mice","volume":"139","author":"Coffey","year":"2022","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3324\/haematol.2012.077446","article-title":"Inappropriately Low Hepcidin Levels in Patients with Myelodysplastic Syndrome Carrying a Somatic Mutation of SF3B1","volume":"98","author":"Ambaglio","year":"2013","journal-title":"Haematologica"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron Metabolism and Iron Disorders Revisited in the Hepcidin Era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41419-022-04891-w","article-title":"Hexokinase 3 Enhances Myeloid Cell Survival via Non-Glycolytic Functions","volume":"13","author":"Seiler","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1574892811666160415160104","article-title":"Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents","volume":"11","author":"Sheng","year":"2016","journal-title":"Recent Pat. Anticancer. Drug Discov."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3892\/etm.2022.11375","article-title":"Prevention of Acute Graft-vs.-host Disease by Targeting Glycolysis and MTOR Pathways in Activated T Cells","volume":"24","author":"Zhou","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41419-021-03400-9","article-title":"SUMOylation Disassembles the Tetrameric Pyruvate Kinase M2 to Block Myeloid Differentiation of Leukemia Cells","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7150\/ijbs.30290","article-title":"Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","article-title":"Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia","volume":"61","author":"Li","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","article-title":"Glutaminase Inhibition in Combination with Azacytidine in Myelodysplastic Syndromes: A Phase 1b\/2 Clinical Trial and Correlative Analyses","volume":"5","author":"DiNardo","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Testa, U., Castelli, G., and Pelosi, E. (2020). Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias. Cancers, 12.","DOI":"10.3390\/cancers12092427"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41375-022-01536-x","article-title":"In Vivo Anti-Tumor Effect of PARP Inhibition in IDH1\/2 Mutant MDS\/AML Resistant to Targeted Inhibitors of Mutant IDH1\/2","volume":"36","author":"Gbyli","year":"2022","journal-title":"Leukemia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/blood-2021-146932","article-title":"Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study by the GFM Group","volume":"138","author":"Sebert","year":"2021","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Stempel, J.M., Kewan, T., and Zeidan, A.M. (2025). Advances and Challenges in the Management of Myelodysplastic Syndromes. Cancers, 17.","DOI":"10.3390\/cancers17152469"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2352-3026(19)30284-4","article-title":"Enasidenib in Patients with Mutant IDH2 Myelodysplastic Syndromes: A Phase 1 Subgroup Analysis of the Multicentre, AG221-C-001 Trial","volume":"7","author":"Stein","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/bloodadvances.2022008378","article-title":"Targeted Therapy with the Mutant IDH2 Inhibitor Enasidenib for High-Risk IDH2-Mutant Myelodysplastic Syndrome","volume":"7","author":"DiNardo","year":"2023","journal-title":"Blood Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3816\/CLK.2008.n.026","article-title":"Improved Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy","volume":"2","author":"Leitch","year":"2008","journal-title":"Clin. Leuk."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12098-020-03442-5","article-title":"Efficacy and Safety of Combined Oral Chelation with Deferiprone and Deferasirox on Iron Overload in Transfusion Dependent Children with Thalassemia\u2014A Prospective Observational Study","volume":"88","author":"DivakarJose","year":"2020","journal-title":"Indian J. Pediatr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/14728222.2024.2443081","article-title":"Hepcidin as a Therapeutic Target in Iron Overload","volume":"28","author":"Sandnes","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Li, X., Zou, C., Xiang, X., Zhao, L., Chen, M., Yang, C., and Wu, Y. (2025). Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects. Biomolecules, 15.","DOI":"10.3390\/biom15060761"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Oliva, E.N., Huey, K., Deshpande, S., Turner, M., Chitnis, M., Schiller, E., Tang, D., Yucel, A., Hughes, C., and Shah, F. (2022). A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030895"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.22001","article-title":"Predicted Costs of Iron-chelators in Myelodysplastic Syndromes: A 10-year Analysis Based on Actual Prevalence and Red Cell Transfusion Rates","volume":"86","author":"Durairaj","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmjspcare-2014-000726","article-title":"Health-Related Quality of Life in Transfusion-Dependent Patients with Myelodysplastic Syndromes: A Prospective Study to Assess the Impact of Iron Chelation Therapy","volume":"6","author":"Efficace","year":"2016","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple Myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Utley, A., Lipchick, B., Lee, K.P., and Nikiforov, M.A. (2020). Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells. Cancers, 12.","DOI":"10.3390\/cancers12082117"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Forster, S., Radpour, R., and Ochsenbein, A.F. (2023). Molecular and Immunological Mechanisms of Clonal Evolution in Multiple Myeloma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1243997"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1002\/mco2.146","article-title":"Pathogenesis and Treatment of Multiple Myeloma","volume":"3","author":"Yang","year":"2022","journal-title":"MedComm"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lu, Q., Yang, D., Li, H., Niu, T., and Tong, A. (2024). Multiple Myeloma: Signaling Pathways and Targeted Therapy. Mol. Biomed., 5.","DOI":"10.1186\/s43556-024-00188-w"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood.2022017635","article-title":"How I Treat Multiple Myeloma in Geriatric Patients","volume":"143","author":"Facon","year":"2024","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Dima, D., Jiang, D., Singh, D.J., Hasipek, M., Shah, H.S., Ullah, F., Khouri, J., Maciejewski, J.P., and Jha, B.K. (2022). Multiple Myeloma Therapy: Emerging Trends and Challenges. Cancers, 14.","DOI":"10.3390\/cancers14174082"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ito, S. (2020). Proteasome Inhibitors for the Treatment of Multiple Myeloma. Cancers, 12.","DOI":"10.3390\/cancers12020265"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"100974","DOI":"10.1016\/j.neo.2024.100974","article-title":"Targeting Myeloma Metabolism: How Abnormal Metabolism Contributes to Multiple Myeloma Progression and Resistance to Proteasome Inhibitors","volume":"50","author":"Zhou","year":"2024","journal-title":"Neoplasia"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy Metabolism in Health and Diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.joca.2015.05.021","article-title":"The Effects of Oxygen Level and Glucose Concentration on the Metabolism of Porcine TMJ Disc Cells","volume":"23","author":"Cisewski","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/stresses3020036","article-title":"Multifactorial Distress, the Warburg Effect, and Respiratory and PH Imbalance in Cancer Development","volume":"3","author":"Drochioiu","year":"2023","journal-title":"Stresses"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/hemato2040049","article-title":"New Targets for PET Imaging of Myeloma","volume":"2","author":"Revheim","year":"2021","journal-title":"Hemato"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-18-2799","article-title":"An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1\u2212HK2+ Multiple Myeloma","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Wang, X., Shen, X., Yan, Y., and Li, H. (2021). Pyruvate Dehydrogenase Kinases (PDKs): An Overview toward Clinical Applications. Biosci. Rep., 41.","DOI":"10.1042\/BSR20204402"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Tataranni, T., Agriesti, F., Pacelli, C., Ruggieri, V., Laurenzana, I., Mazzoccoli, C., Della Sala, G., Panebianco, C., Pazienza, V., and Capitanio, N. (2019). Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines. Cells, 8.","DOI":"10.3390\/cells8050478"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2015.11.023","article-title":"Activation of Mitochondrial Oxidation by PDK2 Inhibition Reverses Cisplatin Resistance in Head and Neck Cancer","volume":"371","author":"Roh","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Barba, I., Carrillo-Bosch, L., and Seoane, J. (2024). Targeting the Warburg Effect in Cancer: Where Do We Stand?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063142"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Arponen, M., Jalava, N., Widjaja, N., and Ivaska, K.K. (2022). Glucose Transporters GLUT1, GLUT3, and GLUT4 Have Different Effects on Osteoblast Proliferation and Metabolism. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.1035516"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","article-title":"Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin","volume":"21","author":"Bajpai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e21344","DOI":"10.1096\/fj.202001920RR","article-title":"Phosphatase of Regenerating Liver-3 Regulates Cancer Cell Metabolism in Multiple Myeloma","volume":"35","author":"Abdollahi","year":"2021","journal-title":"FASEB J."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tan, X.-Q., Guo, A.-Y., Zheng, L.-F., and Xiong, J. (2025). Research Progress on FOXM1 in Ovarian Cancer Diagnosis and Therapeutics. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1598868"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Singh, M.K., Han, S., Kim, S., and Kang, I. (2024). Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252011185"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Chatzikalil, E., Antza, C., Topalidis, C., Kalopitas, G., Solomou, E., Kotsis, V., Germanidis, G., Koufakis, T., and Doumas, M. (2025). Pediatric Familial Hypercholesterolemia: Targeting Intestinal Absorption and Other Therapeutic Strategies. Nutrients, 17.","DOI":"10.3390\/nu17142357"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and Cancer: Emerging Roles in Pathogenesis, Diagnosis and Therapeutic Intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of Cholesterol Homeostasis in Health and Diseases: From Mechanisms to Targeted Therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41420-024-02184-z","article-title":"Fatty Acid Synthase (FASN) Is a Tumor-Cell-Intrinsic Metabolic Checkpoint Restricting T-Cell Immunity","volume":"10","author":"Pedarra","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/pcmedi\/pbz017","article-title":"The Expanded Role of Fatty Acid Metabolism in Cancer: New Aspects and Targets","volume":"2","author":"Chen","year":"2019","journal-title":"Precis. Clin. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","article-title":"Targeting Lipid Metabolism of Cancer Cells: A Promising Therapeutic Strategy for Cancer","volume":"401","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Delmas, D., Cotte, A.K., Connat, J.-L., Hermetet, F., Bouyer, F., and Aires, V. (2023). Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses. Cancers, 15.","DOI":"10.3390\/cancers15164100"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11914-018-0453-9","article-title":"The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone","volume":"16","author":"Diedrich","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e70309","DOI":"10.1002\/ccr3.70309","article-title":"A Case Report of IgA-\u03ba Type Multiple Myeloma Complicated With Hyperlipidemia","volume":"13","author":"Li","year":"2025","journal-title":"Clin. Case Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00277-011-1246-8","article-title":"Low-Density Lipoprotein Cholesterol Suppresses Apoptosis in Human Multiple Myeloma Cells","volume":"91","author":"Medina","year":"2012","journal-title":"Ann. Hematol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Morofuji, Y., Nakagawa, S., Ujifuku, K., Fujimoto, T., Otsuka, K., Niwa, M., and Tsutsumi, K. (2022). Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020151"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional Significance of Cholesterol Metabolism in Cancer: From Threat to Treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2010.131","article-title":"Lipid Raft-Targeted Therapy in Multiple Myeloma","volume":"29","author":"Mollinedo","year":"2010","journal-title":"Oncogene"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2006.050959","article-title":"Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents","volume":"168","author":"Li","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Zheng, X., Huang, Z., Liu, Z., Zheng, Z., Zhang, Y., and Aweya, J.J. (2022). Transcriptome Analysis Reveals That SREBP Modulates a Large Repertoire of Genes Involved in Key Cellular Functions in Penaeus Vannamei, Although the Majority of the Dysregulated Genes Are Unannotated. Genes, 13.","DOI":"10.3390\/genes13112057"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Bessot, A., Gunter, J., McGovern, J., and Bock, N. (2025). Bone Marrow Adipocytes in Cancer: Mechanisms, Models, and Therapeutic Implications. Biomaterials, 322.","DOI":"10.1016\/j.biomaterials.2025.123341"},{"key":"ref_138","first-page":"1245","article-title":"The Immune Microenvironment of Cancer of the Uterine Cervix","volume":"39","author":"Mastrogeorgiou","year":"2024","journal-title":"Histol. Histopathol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.21037\/tcr-24-52","article-title":"Relationship between Adipocytes and Hematological Tumors in the Bone Marrow Microenvironment: A Literature Review","volume":"13","author":"Li","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Baldelli, S., Aiello, G., Mansilla Di Martino, E., Campaci, D., Muthanna, F.M.S., and Lombardo, M. (2024). The Role of Adipose Tissue and Nutrition in the Regulation of Adiponectin. Nutrients, 16.","DOI":"10.3390\/nu16152436"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.2021013832","article-title":"Multiple Myeloma Cells Induce Lipolysis in Adipocytes and Uptake Fatty Acids through Fatty Acid Transporter Proteins","volume":"139","author":"Panaroni","year":"2022","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-20-1088","article-title":"Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype","volume":"81","author":"Fairfield","year":"2021","journal-title":"Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CRD.0b013e3181c4b508","article-title":"Apolipoprotein A-I Mimetic Peptides: A Potential New Therapy for the Prevention of Atherosclerosis","volume":"18","author":"Sherman","year":"2010","journal-title":"Cardiol. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","article-title":"Amino Acid Metabolism in Health and Disease","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Averous, J., Lambert-Langlais, S., Mesclon, F., Carraro, V., Parry, L., Jousse, C., Bruhat, A., Maurin, A.-C., Pierre, P., and Proud, C.G. (2016). GCN2 Contributes to MTORC1 Inhibition by Leucine Deprivation through an ATF4 Independent Mechanism. Sci. Rep., 6.","DOI":"10.1038\/srep27698"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/bloodadvances.2020001639","article-title":"Amino Acid Depletion Triggered by \u029f-Asparaginase Sensitizes MM Cells to Carfilzomib by Inducing Mitochondria ROS-Mediated Cell Death","volume":"4","author":"Soncini","year":"2020","journal-title":"Blood Adv."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Plano, F., Gigliotta, E., Corsale, A.M., Azgomi, M.S., Santonocito, C., Ingrasc\u00ec, M., Di Carlo, L., Augello, A.E., Speciale, M., and Vullo, C. (2023). Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108852"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ejh.12936","article-title":"Intracellular Iron Overload Leading to DNA Damage of Lymphocytes and Immune Dysfunction in Thalassemia Major Patients","volume":"99","author":"Shaw","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"0300060520987396","DOI":"10.1177\/0300060520987396","article-title":"The Iron Chelator Deferoxamine Decreases Myeloma Cell Survival","volume":"49","author":"Yang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3109\/10428194.2014.891025","article-title":"Ferritin as Prognostic Marker in Multiple Myeloma Patients Undergoing Autologous Transplantation","volume":"55","author":"Ludwig","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_151","first-page":"2416","article-title":"CD38 Deletion of Human Primary NK Cells Eliminates Daratumumab-Induced Fratricide and Boosts Their Effector Activity","volume":"136","author":"Nagai","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41375-020-0810-4","article-title":"Daratumumab Induces Mechanisms of Immune Activation through CD38+ NK Cell Targeting","volume":"35","author":"Viola","year":"2021","journal-title":"Leukemia"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Pinto, V.M., and Forni, G.L. (2020). Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228771"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2023-188539","article-title":"Evolving Changes in the Characteristics of Death in Transfusion Dependent Thalassemia in Greece","volume":"142","author":"Delaporta","year":"2023","journal-title":"Blood"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood-2024-206111","article-title":"Abrupt Increases in Ferritin Levels May Indicate a Malignant Process and Not Changes in Iron Overload in Thalassemic Patients","volume":"144","author":"Delaporta","year":"2024","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Zhang, D.-L., Ghosh, M.C., and Rouault, T.A. (2014). The Physiological Functions of Iron Regulatory Proteins in Iron Homeostasis\u2014An Update. Front. Pharmacol., 5.","DOI":"10.3389\/fphar.2014.00124"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Duca, L., Di Pierro, E., Scaramellini, N., Granata, F., and Graziadei, G. (2025). The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136433"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00424-017-1944-8","article-title":"\u201cPumping Iron\u201d\u2014How Macrophages Handle Iron at the Systemic, Microenvironmental, and Cellular Levels","volume":"469","author":"Nairz","year":"2017","journal-title":"Pfl\u00fcgers Arch.-Eur. J. Physiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2015.07.018","article-title":"Oxidative Stress in \u03b2-Thalassaemia and Sickle Cell Disease","volume":"6","author":"Voskou","year":"2015","journal-title":"Redox Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.immuni.2025.08.008","article-title":"Oxidative-Stress-Induced Telomere Instability Drives T Cell Dysfunction in Cancer","volume":"58","author":"Rivadeneira","year":"2025","journal-title":"Immunity"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Gluba-Brz\u00f3zka, A., Franczyk, B., Rysz-G\u00f3rzy\u0144ska, M., Rokicki, R., Koziarska-Ro\u015bciszewska, M., and Rysz, J. (2021). Pathomechanisms of Immunological Disturbances in \u03b2-Thalassemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189677"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.2147\/DDDT.S543211","article-title":"Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics","volume":"19","author":"Alum","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Martyshkina, Y.S., Tereshchenko, V.P., Bogdanova, D.A., and Rybtsov, S.A. (2023). Reliable Hallmarks and Biomarkers of Senescent Lymphocytes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115653"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Musharraf, S.G., Iqbal, A., Ansari, S.H., Parveen, S., Khan, I.A., and Siddiqui, A.J. (2017). \u03b2-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals. Sci. Rep., 7.","DOI":"10.1038\/srep42249"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4812993","DOI":"10.1155\/2022\/4812993","article-title":"Amelioration of Age-Related Multiple Neuronal Impairments and Inflammation in High-Fat Diet-Fed Rats: The Prospective Multitargets of Geraniol","volume":"2022","author":"Abdulmalek","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Ceja-Galicia, Z.A., Cespedes-Acu\u00f1a, C.L.A., and El-Hafidi, M. (2025). Protection Strategies Against Palmitic Acid-Induced Lipotoxicity in Metabolic Syndrome and Related Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020788"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Biggelaar, L.J.C.J.d., Eussen, S.J.P.M., Sep, S.J.S., Mari, A., Ferrannini, E., Dongen, M.C.J.M.v., Denissen, K.F.M., Wijckmans, N.E.G., Schram, M.T., and Kallen, C.J.v.d. (2017). Associations of Dietary Glucose, Fructose, and Sucrose with \u03b2-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht Study. Nutrients, 9.","DOI":"10.3390\/nu9040380"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/EBC20200067","article-title":"Mammalian Lipids: Structure, Synthesis and Function","volume":"65","author":"Cockcroft","year":"2021","journal-title":"Essays Biochem."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Carta, G., Murru, E., Banni, S., and Manca, C. (2017). Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00902"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Alruwaili, N., and Alshdayed, F. (2023). Fructose Metabolism and Its Effect on Glucose-Galactose Malabsorption Patients: A Literature Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13020294"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Le Calv\u00e9, S., Somme, D., Prud\u2019homm, J., and Corvol, A. (2017). Blood Transfusion in Elderly Patients with Chronic Anemia: A Qualitative Analysis of the General Practitioners\u2019 Attitudes. BMC Fam. Pract., 18.","DOI":"10.1186\/s12875-017-0647-8"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Raffa, M., Atig, F., Mhalla, A., Kerkeni, A., and Mechri, A. (2011). Decreased Glutathione Levels and Impaired Antioxidant Enzyme Activities in Drug-Naive First-Episode Schizophrenic Patients. BMC Psychiatry, 11.","DOI":"10.1186\/1471-244X-11-124"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3324\/haematol.2015.139139","article-title":"Metabolic Pathways That Correlate with Post-Transfusion Circulation of Stored Murine Red Blood Cells","volume":"101","author":"Fu","year":"2016","journal-title":"Haematologica"},{"key":"ref_174","first-page":"2017","article-title":"Mimicking Lighting-Induced Electrochemistry on the Early Earth","volume":"120","author":"Jiang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/ddc3010008","article-title":"Beta-Thalassemia: A Pharmacological Drug-Based Treatment","volume":"3","author":"Biswas","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Iqbal, A., Ansari, S.H., Parveen, S., Khan, I.A., Siddiqui, A.J., and Musharraf, S.G. (2018). Hydroxyurea Treated \u03b2-Thalassemia Children Demonstrate a Shift in Metabolism Towards Healthy Pattern. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-33540-6"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1530-0277.1986.tb05161.x","article-title":"Plasma Fatty Acid Pattern Including Diene-conjugated Linoleic Acid in Ethanol Users and Patients with Ethanol-related Liver Disease","volume":"10","author":"Szebeni","year":"1986","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1291\/hypres.31.623","article-title":"Fasting Serum Free Fatty Acid Composition, Waist\/Hip Ratio and Insulin Activity in Essential Hypertensive Patients","volume":"31","author":"Wang","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ma, Z., Min, L., Li, H., Wang, B., Zhong, J., and Dai, L. (2015). Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/183624"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12944-024-02246-2","article-title":"Beneficial Effects of Linoleic Acid on Cardiometabolic Health: An Update","volume":"23","author":"Jackson","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.plefa.2012.12.004","article-title":"Erythrocyte Omega-3 Fatty Acids Increase and Linoleic Acid Decreases with Age: Observations from 160,000 Patients","volume":"88","author":"Harris","year":"2013","journal-title":"Prostaglandins. Leukot. Essent. Fat. Acids"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Botta, A., Forest, A., Daneault, C., Pantopoulos, K., Tantiworawit, A., Phrommintikul, A., Chattipakorn, S., Chattipakorn, N., Des Rosiers, C., and Sweeney, G. (2021). Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients. Metabolites, 11.","DOI":"10.3390\/metabo11020070"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00277-019-03737-4","article-title":"MiR-144 Regulates Oxidative Stress Tolerance of Thalassemic Erythroid Cell via Targeting NRF2","volume":"98","author":"Srinoun","year":"2019","journal-title":"Ann. Hematol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.arcmed.2012.02.003","article-title":"Distortion of \u03b2-Globin Chain of Hemoglobin Alters the Pathway of Erythrocytic Glucose Metabolism through Band 3 Protein","volume":"43","author":"Chakraborty","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1994.tb05072.x","article-title":"In Vivo Metabolic Studies of Glucose, ATP and 2, 3-DPG in \u0392-thalassaemia Intermedia, Heterozygous \u0392-thalassaemic and Normal Erythrocytes: 13C and 31P MRS Studies","volume":"88","author":"Ting","year":"1994","journal-title":"Br. J. Haematol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1182\/blood-2019-129996","article-title":"Decreased Activity and Stability of Pyruvate Kinase in Hereditary Hemolytic Anemia: A Potential Target for Therapy by AG-348 (Mitapivat), an Allosteric Activator of Red Blood Cell Pyruvate Kinase","volume":"134","author":"Rab","year":"2019","journal-title":"Blood"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/hematology.2023000468","article-title":"Pyruvate Kinase Activators: Targeting Red Cell Metabolism in Thalassemia","volume":"2023","author":"Kuo","year":"2023","journal-title":"Hematology"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(25)00635-X","article-title":"Mitapivat in Adults with Non-Transfusion-Dependent \u03b1-Thalassaemia or \u03b2-Thalassaemia (ENERGIZE): A Phase 3, International, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"406","author":"Taher","year":"2025","journal-title":"Lancet"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1002\/hem3.109","article-title":"Metabolic Blood Profile and Response to Treatment with the Pyruvate Kinase Activator Mitapivat in Patients with Sickle Cell Disease","volume":"8","author":"Ruiter","year":"2024","journal-title":"HemaSphere"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e158447","DOI":"10.1172\/JCI158447","article-title":"Mitochondrial Dysfunction in Cell Senescence and Aging","volume":"132","author":"Miwa","year":"2022","journal-title":"J. Clin. Invest."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"104153","DOI":"10.1016\/j.exphem.2024.104153","article-title":"Metabolic Regulation of Erythrocyte Development and Disorders","volume":"131","author":"Lyu","year":"2024","journal-title":"Exp. Hematol."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Khungwanmaythawee, K., Sornjai, W., Paemanee, A., Jaratsittisin, J., Fucharoen, S., Svasti, S., Lithanatudom, P., Roytrakul, S., and Smith, D.R. (2016). Mitochondrial Changes in \u03920-Thalassemia\/Hb E Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153831"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcmd.2011.06.005","article-title":"Increased Oxidative Metabolism Is Associated with Erythroid Precursor Expansion in \u03920-Thalassaemia\/Hb E Disease","volume":"47","author":"Leecharoenkiat","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Suriyun, T., Winichagoon, P., Fucharoen, S., and Sripichai, O. (2022). Impaired Terminal Erythroid Maturation in \u03920-Thalassemia\/HbE Patients with Different Clinical Severity. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071755"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming Growth Factor-\u03b2 Superfamily Ligand Trap ACE-536 Corrects Anemia by Promoting Late-Stage Erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e172656","DOI":"10.1172\/jci.insight.172656","article-title":"Mitapivat Reprograms the RBC Metabolome and Improves Anemia in a Mouse Model of Hereditary Spherocytosis","volume":"8","author":"Matte","year":"2023","journal-title":"JCI Insight"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"eadn8750","DOI":"10.1126\/sciadv.adn8750","article-title":"PGC-1\u03b1 Agonism Induces Fetal Hemoglobin and Exerts Antisickling Effects in Sickle Cell Disease","volume":"10","author":"Sun","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Di Pierro, E., Di Stefano, V., Migone De Amicis, M., and Graziadei, G. (2025). Are Mitochondria a Potential Target for Treating \u03b2-Thalassemia?. J. Clin. Med., 14.","DOI":"10.3390\/jcm14041095"},{"key":"ref_199","first-page":"142","article-title":"Hepcidin Levels, Markers of Iron Overload, and Liver Damage in Patients with Beta Thalassemia Major","volume":"3","author":"Jabeen","year":"2025","journal-title":"Rev. J. Neurol. Med. Sci. Rev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s12325-022-02421-w","article-title":"TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis","volume":"40","author":"Ganz","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Katsarou, A., and Pantopoulos, K. (2018). Hepcidin Therapeutics. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040127"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Nyffenegger, N., Flace, A., Doucerain, C., D\u00fcrrenberger, F., and Manolova, V. (2021). The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of \u03b2-Thalassemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020873"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V122.21.429.429","article-title":"An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction","volume":"122","author":"Wallace","year":"2013","journal-title":"Blood"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Longo, F., and Piga, A. (2022). Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175119"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Chatzikalil, E., Stergiou, I.E., Papadakos, S.P., Konstantinidis, I., and Theocharis, S. (2024). The Clinical Relevance of the EPH\/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073834"},{"key":"ref_206","first-page":"20","article-title":"Shedding Light on the Role of LAG-3 in Hepatocellular Carcinoma: Unraveling Immunomodulatory Pathways","volume":"10","author":"Arvanitakis","year":"2024","journal-title":"Hepatoma Res."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Chatzikalil, E., Vakadaris, G., Reppas, L., Arvanitakis, K., Koufakis, T., Siakavellas, S.I., Manolakopoulos, S., Germanidis, G., and Theocharis, S. (2024). Exploring the Role of GITR\/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma. Cancers, 16.","DOI":"10.3390\/cancers16142609"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez, V.J., Mart\u00edn-Rodr\u00edguez, A., Redondo-Fl\u00f3rez, L., L\u00f3pez-Mora, C., Y\u00e1\u00f1ez-Sep\u00falveda, R., and Tornero-Aguilera, J.F. (2023). New Insights and Potential Therapeutic Interventions in Metabolic Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310672"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Chatzikalil, E., Arvanitakis, K., Vakadaris, G., Stergiou, I.E., Koutsompina, M.-L., Argyrou, A., Lekakis, V., Konstantinidis, I., and Germanidis, G. (2024). Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications. Cancers, 16.","DOI":"10.3390\/cancers16081533"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12032-024-02575-3","article-title":"Metabolic Dysregulation in Myelodysplastic Neoplasm: Impact on Pathogenesis and Potential Therapeutic Targets","volume":"42","author":"Zhou","year":"2024","journal-title":"Med. Oncol."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Gavriatopoulou, M., Paschou, S.A., Ntanasis-Stathopoulos, I., and Dimopoulos, M.A. (2021). Metabolic Disorders in Multiple Myeloma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111430"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination Therapy in Combating Cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic Drug Combinations Tend to Improve Therapeutically Relevant Selectivity","volume":"27","author":"Krueger","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor Biomarkers for Diagnosis, Prognosis and Targeted Therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"O\u2019Brien III, W.G., Berka, V., Tsai, A.-L., Zhao, Z., and Lee, C.C. (2015). CD73 and AMPD3 Deficiency Enhance Metabolic Performance via Erythrocyte ATP That Decreases Hemoglobin Oxygen Affinity. Sci. Rep., 5.","DOI":"10.1038\/srep13147"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114525105345","article-title":"2,3-Diphosphoglycerate: The Forgotten Metabolic Regulator of Oxygen Affinity","volume":"10","author":"Jaafar","year":"2025","journal-title":"Br. J. Nutr."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bjh.18586","article-title":"Erythrocyte Type 1 Equilibrative Nucleoside Transporter Expression in Sickle Cell Disease and Sickle Cell Trait","volume":"200","author":"Koehl","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"100290","DOI":"10.1016\/j.metop.2024.100290","article-title":"Clinical Metabolomics: Useful Insights, Perspectives and Challenges","volume":"22","author":"Dalamaga","year":"2024","journal-title":"Metab. Open"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.21037\/tp-22-105","article-title":"A Narrative Review of Metabolomics in the Era of \u201c-Omics\u201d: Integration into Clinical Practice for Inborn Errors of Metabolism","volume":"11","author":"Hertzog","year":"2021","journal-title":"Transl. Pediatr."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Armakolas, A., Kotsari, M., and Koskinas, J. (2023). Liquid Biopsies, Novel Approaches and Future Directions. Cancers, 15.","DOI":"10.3390\/cancers15051579"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.30574\/ijsra.2023.8.1.0189","article-title":"Artificial Intelligence in Multi-Omics Data Integration: Advancing Precision Medicine, Biomarker Discovery and Genomic-Driven Disease Interventions","volume":"8","author":"Ali","year":"2023","journal-title":"Int. J. Sci. Res. Arch."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized Medicine: Motivation, Challenges, and Progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil. Steril."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/22\/1788\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:48:59Z","timestamp":1763131739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/22\/1788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":222,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["cells14221788"],"URL":"https:\/\/doi.org\/10.3390\/cells14221788","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}